AP Photo 6 days ago

From left, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention Director Dr. Anne Schuchat, Assistant Health and Human Services Secretary for Preparedness and Response, Dr. Nicole Lurie; and Acting Chief Scientist FDA Dr. Jesse Goodman, a...

AP Photo 1 week ago

"Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of DuraSeal(TM) spine sealant, the first product approved by the FDA for intra-operative sealing of the dural membrane during spine procedures."

Tilapia fish gather at a viewing window in their holding tank at the U.S. Food and Drug Administration's (FDA) Center for Veterinary Medicine labs in Laurel, Maryland, November 5, 2009.

Staff walk among the new buildings at the the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 5, 2009.

Plants are lined up to be planted among new buildings at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 5, 2009.

A high resolution digital scan shows the cell-level detail of a rat's kidney during a tour of the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 5, 2009.

A high-magnification microscope is shown during a tour of the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 5, 2009.

A digital scan of a rat kidney is shown on a screen at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 5, 2009.

A rat genome gene chip is shown to the media by Karol Thompson, Lead Pharmacologist in the Molecular Toxicology lab at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 5, 2009. Watching on is biologist Barry Rosenzweig.

An illustration of a kidney and samples are shown in the Investigational Pathology lab at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 5, 2009.

Rodney Rouse, Veterinary Medical Officer at the U.S. Food and Drug Administration (FDA), shows a chart of biology scans to science industry writers at the FDA headquarters in Silver Spring, Maryland, November 5, 2009.

Jun Zhang, Toxicologic Pathologist/Pharmacologist at the U.S. Food and Drug Administration (FDA), speaks to the media alongside a digital scan of a kidney during a tour of the FDA headquarters in Silver Spring, Maryland, November 5, 2009.

A slide of rat kidneys are prepared for digital scanning for medical analysis at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 5, 2009.

A rat genome gene chip is shown in the Molecular Toxicology lab at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 5, 2009.

Rat genome gene chips are shown in the Molecular Toxicology lab at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 5, 2009.

A science writer wears a pair of polarized glasses to view a Polarization Stereoscopic display during a tour of the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 4, 2009.

Dr Aldo Badano shows images of real human breast (R) and an computer-generated one (2nd R) during a demonstration of computational models of 3D novel 3D breast imaging systems at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 4, 2009.

Dr Aldo Badano shows images of a fake (L) and real human skeleton during a demonstration of computational models of 3D imaging systems at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 4, 2009.

Science writers are giving a tour of an electromagnic environment chamber during a tour of the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 4, 2009.

A new building is shown during construction at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 4, 2009.

The headquarters of the U.S. Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009.

An image of a human skull is shown in a Polarization Stereoscopic display during a tour of the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 4, 2009.

A laboratory staff conducts an experiment in a Magnetic Resonance Imaging (MRI) chamber inside a lab at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 4, 2009.

The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009.

Biosensors, involving fluorescence resonance energy transfer using peptide substrates, glow in different colours during a lab tour for media from the science industry at the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 4, 2009.